The Worlds Leading Brands In Entertainment Are Making A Change

Over the past couple of years, big brands ranging from LG to Toshiba, Dynaudio, Enclave Audio, Bang & Olufsen, Klipsch and more have been making the WiSA switch, creating a simplified, yet immersive home audio experience for consumers and a massive opportunity for investors!

WiSA Simplifies Home Immersive Sound

A technology that is quickly becoming the standard in home entertainment, WiSA simplifies home immersive sound. WiSA Ready devices make it possible to set up theater quality sound without running wires, and to do so at a fraction of the cost of a home surround sound system.

About Biotech Stocks

What Are Tech Stocks Stocks?

Tech stocks are stocks that represent technology companies. These companies focus on the development of the latest and greatest in technology. Perhaps, one of the most popular tech stocks is known as Apple (AAPL), the maker of the iPhone.

While there are only a few tech companies that have become household names, there are thousands of companies on the market in the sector. Here’s what you should look for when investing in tech stocks.

  • Innovation – Technology is fueled by innovation. The latest and greatest in tech today may become old news within a year. If you’re going to invest in tech, you want to make sure to do so with companies that are constantly looking to improve their products.
  • IP – In the world of technology, IP, or intellectual property, is the name of the game. Ultimately, without patents, trademarks, and other forms of IP, companies have no way of protecting themselves from competition. So, when investing in tech, make sure to look for companies with plenty of IP.
  • Balance Sheet – Many early stage tech companies are not sound financially. When making an investment decision in the space, it’s a good idea to look at the company’s balance sheet to see if it has the money to survive through an extended period of time.
  • Management Team – Management teams make the decisions that will make a company successful or a failure. Therefore, it’s a good idea to look into the history of the management team that governs the company before making a decision to buy its stock.
  • Analyst Ratings – No matter if it’s tech or another space, analysts are paid to analyze opportunities in the market. While it’s not a good idea to blindly follow analysts, it’s a good idea to look to them for back up in order to validate your decision.

Latest Biotech Stock News

FuelCell Energy FCEL Stock News

FuelCell Energy (FCEL) Stock Could Go Far Higher!

FuelCell Energy Inc (NASDAQ: FCEL) has had a strong run in the market as of late. Fuelled by a recent the development and launch...
Cemtrex CETX Stock News

Cemtrex (CETX) Stock Rockets On New $700,000 Order

Cemtrex Inc (NASDAQ: CETX) is making a run for the top in the market this morning, trading on gains of more than 80%. The...

Get FREE Tech Stock News Alerts

Sign up for our FREE mailing list below to receive real-time alerts sent directly to your inbox!

Income Statement

This website/newsletter is owned, operated and edited by CNA Finance, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “CNA Finance” refers to CNA Finance, LLC. This webpage/newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to publish information and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners do not own any shares in stocks mentioned unless stated in page disclosures. If we own any shares we will list the information relevant to the stock and number of shares here. CNA Finance, parent company to Alpha Stock News, receives payment to publish content and promote publicly traded companies. Pursuant to an agreement between CNA Finance and Cellectar Biosciences, CNA Finance has been hired for a period beginning on 12/1/19 and ending on 12/31/19 to conduct digital advertising and marketing and publicly disseminate information about CLRB via Websites and Email. We have been paid an upfront payment of fifteen thousand dollars via bank wire transfer. We own zero shares of Cellectar Biosciences. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated digital outreach efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of digital outreach marketing, which may end as soon as the marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct and Cellectar Biosciences has not approved the content of this site. Furthermore, CNA Finance often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.